Biotech

All Articles

Editas exploit Vertex Cas9 licensing civil rights for $57M

.Against the background of a Cas9 patent battle that refuses to pass away, Editas Medication is cash...

Ultragenyx changes genetics therapy dosing to dial up efficiency

.A minority of people taking Ultragenyx Pharmaceutical's Wilson disease gene therapy UX701 have come...

Biopharma cutback fee stabilizes in Q3: Tough Biotech analysis

.As summer months heat turns to cool winds, really hopes that this year would certainly bring common...

J &amp J loses period 2 dengue candidate in most up-to-date shift from injections

.Johnson &amp Johnson's deprioritization of its own contagious ailment pipe has actually claimed yet...

Relay sheds 10% of staff after earlier layoffs in July

.Accuracy medicine biotech Relay Therapeutics is losing approximately 10% of its own staff in initia...

Pentixapharm credit ratings $22M IPO to allowance radiopharma tests

.Pentixapharm has actually brought in virtually 20 thousand euros ($ 22 thousand) coming from an IPO...

Lundbeck taps Charles Stream for AI-enabled neuro drug finding

.Lundbeck has actually tapped Charles Stream Laboratories' expert system capabilities to help the di...

Big pharma, biotech 'won't automatically be symbiotic' in AI: S&ampP

.Big Pharma is actually putting in heavily in AI to reduce growth timelines as well as foster innova...

I &amp I biotech Triveni raises $115M for preclinical antitoxins

.Triveni Bio has roped in $115 thousand in set B funds to accelerate preclinical antitoxin plans des...

IGM turns coming from cancer cells to autoimmune, agitating C-suite

.IGM Biosciences ended in 2015 giving up team as well as streamlining its own cancer cells pipeline....